SecBot SecBot
PRESS-RELEASE ·Filed May 15, 2026

REGN

Regeneron Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a routine corporate philanthropy press release with zero trading implications. No action required, ignore for investment purposes.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$696.20
T+0 close · May 15, 2026 · via day close
Latest settled
+14.46%
T+60 · $796.84
Vs SPY
+10.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $696.20entry
  2. T+1 · 6mo ago −9.60%α −9.54% · $629.34
  3. T+5 · 6mo ago −8.28%α −9.25% · $638.53
  4. T+20 · 5mo ago −11.67%α −13.78% · $614.98
  5. T+60 · 3mo ago +14.46%α +10.21% · $796.84

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Regeneron announced the winners of its 2026 International Science and Engineering Fair (ISEF), awarding over $7 million in prizes to high school students. This is a philanthropic/PR event with no direct financial impact on Regeneron's business or stock.

Key Facts

  • Regeneron ISEF 2026 awarded over $7 million in prizes to more than 1,700 finalists from 67+ countries
  • Top prize: $100,000 George D. Yancopoulos Innovator Award to Hikaru Kuribayashi for origami-folding simulation software
  • Regeneron's total support for ISEF and Science Talent Search will exceed $300 million from 2017 to 2036
  • No financial results, guidance, or business developments disclosed

Financial Impact

No revenue or earnings impact; $300M total sponsorship commitment through 2036 is a pre-existing, non-material expense for a $74.7B market cap company

Risk Factors

  • None from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (38 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3296082

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026